http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003139465-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
| filingDate | 2002-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d82a7a2e52b85337904188676c9ea9 |
| publicationDate | 2003-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003139465-A1 |
| titleOfInvention | Selected essential amino acid supplementation of dietary proteins to lower urinary urea and peak glucose levels |
| abstract | Depending upon the quantity of protein being consumed, one or more unit doses of a blend consisting of L-Tryptophan (80 mgs), L-Methionine (90 mgs), L-Valine (103 mgs) and L-Lysine Monohydrochloride (128 mgs), added as a dietary supplement, will improve the efficiency of amino acid utilization and thereby lower urinary urea excretion and control peak post-prandial blood glucose levels. The levels of supplementation are derived by taking into consideration the average human fasting plasma concentrations of essential amino acids and L-Tyrosine and L-Cystine. |
| priorityDate | 2002-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.